Cargando…
Multisystem inflammatory syndrome in an adult following the SARS-CoV-2 vaccine (MIS-V)
SARS-CoV-2 vaccine roll-out has been successful in the UK and other parts of the world; however, there are increasing concerns about adverse events. A 44-year-old woman presented to a UK hospital with left upper arm pain at the vaccine site a couple of days after receiving the Pfizer-BioNTech mRNA v...
Autores principales: | Nune, Arvind, Iyengar, Karthikeyan P, Goddard, Christopher, Ahmed, Ashar E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8323360/ https://www.ncbi.nlm.nih.gov/pubmed/34326117 http://dx.doi.org/10.1136/bcr-2021-243888 |
Ejemplares similares
-
Multisystem Inflammatory Syndrome (MIS) following SARS-CoV-2 vaccinations; a systematic review
por: Elsaid, Mohamed, et al.
Publicado: (2023) -
SARS-CoV-2 and Multisystem Inflammatory Syndrome In Children (MIS-C)
por: Matic, Kathleen M.
Publicado: (2021) -
Multisystem Inflammatory Syndrome in Children (MIS-C) Following SARS-CoV-2 Infection: Role of Oxidative Stress
por: Graciano-Machuca, Omar, et al.
Publicado: (2021) -
Multisystem Inflammatory Syndrome in Children (MIS-C) Related to SARS-CoV-2 and 1-Year Follow-up
por: Kapoor, Rashmi, et al.
Publicado: (2022) -
Neonatal Multisystem Inflammatory Syndrome (MIS-N) Associated with Maternal SARS-CoV-2 Exposure
por: Gupta, Priyanka, et al.
Publicado: (2022)